Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · January 15, 2023

Outcomes of Intravitreal Delivery of the rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients With X-Linked Retinoschisis

Ophthalmology Retina


Additional Info

Ophthalmology Retina
Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results
Ophthalmol Retina 2022 Dec 01;6(12)1130-1144, ME Pennesi, P Yang, DG Birch, CY Weng, AT Moore, A Iannaccone, JI Comander, T Jayasundera, J Chulay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading